Feeling mild COVID-19 symptoms? For the safety of our community, you do NOT need to visit the emergency department unless critical symptoms are experienced. Visit our COVID-19 hub to learn more.Visit the COVID-19 Hub
Nyingi Kemmer, M.D., M.P.H., M.Sc., has been a member of the TGMG liver transplant team since July 2011. Prior to her joining the group she was an associate professor of medicine at the University of Cincinnati, OH. Dr Kemmer completed her medical degree at the University of Sokoto in Sokoto, Nigeria and a residency at Cook County Hospital in Chicago, IL. Dr. Kemmer went on to complete her gastroenterology training at the University of Texas Medical Group, Galveston, TX, and transplant hepatology fellowship training at the Scripps Clinic, La Jolla, CA. She is actively involved in clinical research and completed her M.P.H. with a focus on outcomes research and M.Sc. in drug development and pharmacogenomics.
Her research interest is in the area of health related quality of life, clinical outcomes and disparities in liver transplantation. Her research pertaining to transplant immunosuppression, clinical outcomes and disparities in liver transplantation has been published in numerous journals including Liver Transplantation, Transplantation Journal, Transplant Proceedings, Liver International and Hepatology.
She is a member of many professional medical societies and has been a reviewer of abstracts (disparities and outcomes in transplantation) for the American Society of Transplantation annual ATC meetings.